Keeping an eye on social media

Article

From Facebook to Twitter, individuals are embracing the opportunity to participate in online publishing at an unprecedented rate. Communities of users interact globally, minute-to-minute within huge databases of content that they themselves create.

From Facebook to Twitter, individuals are embracing the opportunity to participate in online publishing at an unprecedented rate. Communities of users interact globally, minute-to-minute within huge databases of content that they themselves create.

The social media revolution has even spread to the perhaps over-cautious Ophthalmology market. According to ASCRS's Eyeworld, ophthalmologists are experimenting with Facebook and YouTube channels.

But don't get too excited. Ophthalmology-sponsored patient communities are a long way from being ubiquitous on the internet. The industry still can't quite get its collective head around the removal of the "learned intermediary" and is definitely not ready to turn a supply of drug information and advice over to the patient community.

So what good is social media to the ophthalmology sector? Well if we leave marketing and patient education to one side, and assume that there's no real value in a "Texas Hold Em" (poker for the uninitiated) tournament on Facebook, professional networking surely remains the most exciting Web 2.0 activity for ophthalmologists.

Dominating the online professional networking space is LinkedIn, the world's largest network with over 35 million members worldwide, 9 million of them in Europe.

The LinkedIn site is basically a database of individual profiles. Users are provided with the tools to manage and maintain their profile, connect to others on the network, share knowledge, expertise and potential opportunities.

"The subject matter of LinkedIn is the individual. While people talk about their companies and products, the main thing that you'll find with the site is people," says Steven Tylock, author of The Linkedin Personal Trainer.

Tylock explains that LinkedIn helps bridge one-to-one introductions that may lead to any number of activities and that the real benefit of online networking is the way it extends the networker's reach.

"You would never call 200 people to ask if they know anyone at XYZ Company. It just isn't practical," says Tylock. "It is easy to search through that many people on LinkedIn; then you are calling one person to ask them to introduce you to their contact at XYZ Company."

Bucking broader recessionary trends, LinkedIn is expanding internationally. Earlier this month it added a dedicated German site to service 500,000 German users already registered. The company launched sites in France and Spain last year.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.